NPTH.V - Biomed/telehealth stock trading below 1x revenues
NPTH is significantly undervalued compared to peers:
- $33M mkt cap with $50M revenue in 2019
- < 1 EV/sales vs 18.24x industry avg
- Recent $12M financing at .90
- Insider options at .87 + open market buys
- In major historical support zone
- $33M mkt cap with $50M revenue in 2019
- < 1 EV/sales vs 18.24x industry avg
- Recent $12M financing at .90
- Insider options at .87 + open market buys
- In major historical support zone
